Literature DB >> 15086533

Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.

Yun Min Ding1, Juliann D Jaumotte, Armando P Signore, Michael J Zigmond.   

Abstract

6-Hydroxydopamine (6-OHDA)-induced loss of dopamine (DA) neurons has served to produce an animal model of DA neuron loss in Parkinson's disease. We report here the use of 6-OHDA to produce an in vitro model of this phenomena using dissociated cultures prepared from neonatal rat mesencephalon. Cultures were exposed to 6-OHDA (40-100 microm, 15 min) in an antioxidant medium, and DA and GABA neurons evaluated by immunocytochemistry. 6-OHDA induced morphological and biochemical signs of cell death in DA neurons within 3 h, followed by loss of tyrosine hydroxylase immunoreactive neurons within 2 days. In substantia nigra (SN) cultures, DA neurons were much more affected by 6-OHDA than were GABA neurons. In contrast, DA neurons from the ventral tegmental area were only lost at higher, non-specific concentrations of 6-OHDA. The effects of 6-OHDA on nigral DA neurons were blocked by inhibitors of high affinity DA transport and by z-DEVD-fmk (150 microm), a caspase inhibitor. Glial cell line-derived neurotrophic factor (GDNF) treatment reduced TUNEL labeling 3 h after 6-OHDA exposure, but did not prevent loss of DA neurons at 48 h. Thus, 6-OHDA can selectively destroy DA neurons in post-natal cultures of SN, acting at least in part by initiating caspase-dependent apoptosis, and this effect can be attenuated early but not late by GDNF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086533     DOI: 10.1111/j.1471-4159.2004.02415.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  47 in total

1.  Let-7d microRNA Attenuates 6-OHDA-Induced Injury by Targeting Caspase-3 in MN9D Cells.

Authors:  Li Li; Hui Liu; Haijing Song; Yingsong Qin; Ying Wang; Ming Xu; Chaoxia Liu; Jin Gao; Shen Sun
Journal:  J Mol Neurosci       Date:  2017-10-29       Impact factor: 3.444

2.  Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity.

Authors:  Bin Xing; Tao Xin; Lingling Zhao; Randy L Hunter; Yan Chen; Guoying Bing
Journal:  J Neuroimmunol       Date:  2010-05-14       Impact factor: 3.478

3.  Dopamine transporter is enriched in filopodia and induces filopodia formation.

Authors:  John Caltagarone; Shiqi Ma; Alexander Sorkin
Journal:  Mol Cell Neurosci       Date:  2015-04-30       Impact factor: 4.314

Review 4.  Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression.

Authors:  Hui-Ming Gao; Jau-Shyong Hong
Journal:  Trends Immunol       Date:  2008-07-01       Impact factor: 16.687

5.  LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.

Authors:  Ha Nam Nguyen; Blake Byers; Branden Cord; Aleksandr Shcheglovitov; James Byrne; Prachi Gujar; Kehkooi Kee; Birgitt Schüle; Ricardo E Dolmetsch; William Langston; Theo D Palmer; Renee Reijo Pera
Journal:  Cell Stem Cell       Date:  2011-03-04       Impact factor: 24.633

6.  Regeneration of Dopaminergic Neurons in Adult Zebrafish Depends on Immune System Activation and Differs for Distinct Populations.

Authors:  Lindsey J Caldwell; Nick O Davies; Leonardo Cavone; Karolina S Mysiak; Svetlana A Semenova; Pertti Panula; J Douglas Armstrong; Catherina G Becker; Thomas Becker
Journal:  J Neurosci       Date:  2019-04-04       Impact factor: 6.167

7.  Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons.

Authors:  Jonathan Sagal; Xiping Zhan; Jinchong Xu; Jessica Tilghman; Senthilkumar S Karuppagounder; Li Chen; Valina L Dawson; Ted M Dawson; John Laterra; Mingyao Ying
Journal:  Stem Cells Transl Med       Date:  2014-06-05       Impact factor: 6.940

Review 8.  Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.

Authors:  Fernanda Martins Lopes; Ivi Juliana Bristot; Leonardo Lisbôa da Motta; Richard B Parsons; Fabio Klamt
Journal:  Neuromolecular Med       Date:  2017-07-18       Impact factor: 3.843

9.  Mitogen-activated protein kinase phosphatase (MKP)-1 as a neuroprotective agent: promotion of the morphological development of midbrain dopaminergic neurons.

Authors:  Louise M Collins; Gerard W O'Keeffe; Caitriona M Long-Smith; Sean L Wyatt; Aideen M Sullivan; André Toulouse; Yvonne M Nolan
Journal:  Neuromolecular Med       Date:  2013-04-13       Impact factor: 3.843

10.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.